CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Planned sale Director sold 19,205 shares at $24.01 ($461,112)
- 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 82,121 shares (grant or award)
- 4 Grant or award CSO/EVP Disc & Trans Research acquired 63,350 shares (grant or award)
- 4 Grant or award President and CEO acquired 241,670 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 82,121 shares (grant or award)
- 4 Grant or award EVP, General Counsel & Sec acquired 63,350 shares (grant or award)
- 4 Open-market sale EVP, Commercial sold 47,020 shares at $21.45 ($1,008,579)
- 4 Open-market buy Director bought 190,000 shares at $20.70 ($3,932,734)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 10,630 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 63,717 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 21,862 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 13,061 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 13,613 shares (to pay taxes)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 11,606 shares (to pay taxes)
- 4 Grant or award Director acquired 15,424 shares (grant or award)
- 4 Grant or award Director acquired 15,424 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP, Commercial sold 64,149 shares at an average $23.16 ($1,485,853)
- 4 Planned sale EVP, General Counsel & Sec sold 25,000 shares at $23.01 ($575,250)
Page 9 of 73 · 1,458 filings